Amerise Biosciences Limited Stock

Stocks

AMARDEE6

INE673C01020

Investment Holding Companies

Delayed Bombay S.E. Other stock markets 04:45:00 2026-08-11 EDT			5-day change	1st Jan Change
0.8600 ^INR	0.00%		-6.52%	+40.98%

08-03	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI

Valuation: Amerise Biosciences Limited

Market Cap	38.98M 409K 354K 331K 302K 570K 578K 3.88M 1.52M 19.5M 1.53M 1.5M 64.95M	P/E 2024	-29.8x	P/E 2025	1,056x
Enterprise Value	38.76M 406K 352K 329K 301K 566K 575K 3.86M 1.51M 19.39M 1.53M 1.49M 64.58M	EV / Sales 2024	121x	EV / Sales 2025	31.9x
Free-Float	64.18%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Chart: Amerise Biosciences Limited

Dynamic Chart

Latest news : Amerise Biosciences Limited

08-03	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
05-05	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
02-02	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-02	Amerise Biosciences appoints Albert Hines as CFO	RE
02-02	Amerise Biosciences Limited Announces Chief Financial Officer Changes, Effective February 2, 2026	CI
02-02	Amerise Biosciences Limited Announces Board Changes, Effective February 2, 2026	CI
11-05	Amerise Biosciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-09-24	Amerise Biosciences Limited Appoints Kelash Bunkar as Independent Director, Effective 23 September 2025	CI
25-07-24	Amerise Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-19	Amerise Biosciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2025	CI
25-02-03	Amerise Biosciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024	CI
25-02-03	Amerise Biosciences Limited Announces Resignation of Niraj Vaghela as Independent Director	CI
25-01-27	Swagtam Trading & Services Limited announced that it expects to receive INR 61.904375 million in funding from Jalees Commercial Limited, Shree Ganesh Bio-Tech Limited, Amerise Biosciences Limited, Saianand Commercial Limited and other investors	CI

More news

Quotes and Performance

1 week	-6.52%
Current month	-14.85%
1 month	-2.27%
3 months	+11.69%
6 months	+22.86%
Current year	+40.98%

More quotes

Course Extremes

1 week	0.86	0.96
1 month	0.81	1.03
Current year	0.5	1.03
1 year	0.5	1.03
3 years	0.5	1.45
5 years	0.5	2.73
10 years	0.5	2.73

More quotes

Managers and Directors: Amerise Biosciences Limited

Manager	Title	Age	Since
Albert Hines DFI	Director of Finance/CFO	-	2026-02-01
Soni Pandiya CMP	Compliance Officer	-	2026-04-14

Director	Title	Age	Since
Manisha Maneklal Patel BRD	Director/Board Member	57	2019-06-23
Niraj Vijaybbai Vaghela BRD	Director/Board Member	29	2022-07-22
Albert Hines BRD	Director/Board Member	-	2026-02-01

More insiders

Shell Companies

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AMERISE BIOSCIENCES LIMITED	0.00%	-6.52%	+10.26%	+34.38%	596K
CHURCHILL CAPITAL CORP XI	-3.10%	+4.07%	-	-	897M
PRIME BEING CORP.	+0.91%	+0.91%	+94.74%	+221,900.00%	804M
CENTIEL AG	-4.01%	+0.62%	+270.41%	-71.16%	680M
DRUGS MADE IN AMERICA ACQUISITION II CORP.	+0.10%	+0.10%	-	-	645M
BAIN CAPITAL GSS INVESTMENT CORP.	+0.02%	+0.02%	-	-	596M
CANTOR EQUITY PARTNERS IV, INC.	+0.19%	+0.10%	-	-	595M
AMERICAN EXCEPTIONALISM ACQUISITION CORP. A	-0.78%	+0.44%	-	-	569M
NEW AMERICA ACQUISITION I CORP.	+0.10%	+0.49%	-	-	507M
Average	-0.73%	+8.47%	+125.14%	+73,954.40%	588.09M
Weighted average by Cap.	-0.94%	+9.36%	+175.15%	+120,170.25%

See all sector performances

Financials

	2024	2025
Net sales	359K 3.76K 3.26K 3.05K 2.78K 5.25K 5.33K 35.72K 14.02K 180K 14.13K 13.83K 598K	1.88M 19.71K 17.06K 15.95K 14.58K 27.47K 27.9K 187K 73.39K 941K 74.02K 72.4K 3.13M
Net income	-1.46M -15.32K -13.26K -12.4K -11.33K -21.35K -21.68K -145K -57.04K -731K -57.52K -56.27K -2.43M	57K 597.65 517.39 483.6 441.99 832.89 845.91 5.67K 2.23K 28.52K 2.24K 2.2K 94.97K
Net Debt	-211K -2.21K -1.92K -1.79K -1.64K -3.08K -3.13K -20.99K -8.24K -106K -8.31K -8.13K -352K	-222K -2.33K -2.02K -1.88K -1.72K -3.24K -3.29K -22.09K -8.67K -111K -8.74K -8.55K -370K